Amy Mahery
Direktor/Vorstandsmitglied bei CNS PHARMACEUTICALS, INC.
Vermögen: - $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Amy Mahery
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 25 | |
| Public Company | Pharmaceuticals: Major | 10 | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Amy Mahery
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| SUMITOMO PHARMA CO., LTD. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| STAR EQUITY HOLDINGS, INC. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
Care Fusion, Inc.
 Care Fusion, Inc. Medical SpecialtiesHealth Technology Care Fusion, Inc. provides barcode-enabled positive patient identification products. Its products help to improve patient care, to support medication administration, allergy warnings, safety alerts and complex IVs. The firm works with hospital-based clinicians to design point-of-care solutions that would help create a safer care environment. The company was founded by Kenneth E. Tighe and Navneet Gosal in 2001 and is headquartered in Reston, VA. | Medical Specialties | Corporate Officer/Principal | |
QVT Financial LP
 QVT Financial LP Investment ManagersFinance QVT Financial LP is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2003 by Daniel Gold. QVT Financial provides administrative and/or investment management services to private funds including US limited partnerships, non-US limited partnerships and non-US Corporation. | Investment Managers | Portfolio Manager-Equities Chief Executive Officer Analyst-Equity | |
Shire Regenerative Medicine, Inc.
 Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Shire Regenerative Medicine, Inc. develops and commercializes living cell therapies. It manufactures and markets dermagraft, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 2004 and is headquartered in Westport, CT. | Biotechnology | Comptroller/Controller/Auditor | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| INFUSYSTEM HOLDINGS, INC. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| SCORPIUS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Moleculin LLC
 Moleculin LLC Pharmaceuticals: MajorHealth Technology Moleculin LLC develops dermatological products for treatment of skin disorders. The company was founded by Klemp V. Walter in 2006 and is headquartered in Houston, TX. | Pharmaceuticals: Major | President Director/Board Member | |
Tolero Pharmaceuticals, Inc.
 Tolero Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Tolero Pharmaceuticals, Inc. manufactures and markets pharmaceutical products. It is a clinical-stage biopharmaceutical company with a single-minded purpose to alleviate human suffering through the development of medicines to treat cancer and other serious human diseases. The company is headquartered in Lehi, UT. | Pharmaceuticals: Other | Director/Board Member | |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Masters Business Admin | |
| University of Pennsylvania | College/University | Undergraduate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree Graduate Degree | |
| The Johns Hopkins University | College/University | Masters Business Admin | |
| Yale University | College/University | Undergraduate Degree Masters Business Admin | |
| Western Washington University | College/University | Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Tokyo | College/University | Undergraduate Degree | |
| Eisai Medical Research, Inc. | Corporate Officer/Principal | ||
| Weill Cornell Medical College | College/University | Doctorate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
Dexcel Pharma Technologies Ltd.
 Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Pharmaceuticals: Major | Chief Executive Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree | |
| MIT Sloan School of Management | College/University | Corporate Officer/Principal Masters Business Admin | |
| Yale Law School | College/University | Graduate Degree Graduate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
CUSTOpharm, Inc.
 CUSTOpharm, Inc. Pharmaceuticals: MajorHealth Technology CUSTOpharm, Inc. provides personalized chemistry and regulatory support services. It provides personalized cost-effective chemistry and manufacturing controls (CMC) and regulatory support to companies with limited resources and those seeking to expand into new areas. The firm offers product development services that focus on non-clinical, clinical, marketing, and other aspects of drug development and distribution; sourcing of product manufacturing with specialization in injectable dosage forms, including suspensions, lyophilized, and cytotoxic compounds, technology transfer, regulatory support, such as electronic submissions, electronic hybrids, paper applications/CTD/traditional format, structured product labeling. The company was founded by David McCleary in 2005 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Zanvyl Krieger School of Arts & Sciences | College/University | Undergraduate Degree | |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | President Corporate Officer/Principal Chief Executive Officer Chief Operating Officer | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
| MOLECULIN BIOTECH, INC. | Pharmaceuticals: Major | Founder Director/Board Member Chief Tech/Sci/R&D Officer | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director/Board Member Chairman Director/Board Member Corporate Officer/Principal | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Comptroller/Controller/Auditor Chief Executive Officer President Director of Finance/CFO | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Spinal Elements, Inc.
 Spinal Elements, Inc. Medical SpecialtiesHealth Technology Spinal Elements, Inc. designs, develops, manufactures and markets medical devices used in spinal surgical procedures. It offers cervical, lumbar, biologics and thoracolumbar products. The company was founded by Jason Blain and Steve McGowan in April 2017 and is headquartered in Carlsbad, CA. | Medical Specialties | Director of Finance/CFO | |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Clexio Biosciences Ltd.
 Clexio Biosciences Ltd. Pharmaceuticals: OtherHealth Technology Clexio Biosciences Ltd. develops novel therapies for patients suffering from neurological and psychiatric conditions. The private company is based in Jerusalem, Israel. The Israeli company was founded by Elena Kagan, Elisabeth Kogan, Menashe Levy. Elisabeth Kogan has been the CEO since incorporation. | Pharmaceuticals: Other | Director/Board Member | |
Kriya Therapeutics, Inc.
 Kriya Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kriya Therapeutics, Inc. designs and develops transformative new treatments for prevalent and severe chronic diseases. The company was founded by Shankar Ramaswamy and Roger Jeffs and is headquartered in Redwood City, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| 8400 - The Health Network | Director/Board Member | ||
| QUANTUM-SI INCORPORATED | Packaged Software | Director of Finance/CFO | |
| Roivant Social Ventures, Inc. | Director/Board Member Director/Board Member Director/Board Member |
Statistik
International
| Vereinigte Staaten | 41 |
| Israel | 4 |
| Japan | 3 |
| Deutschland | 2 |
| Kanada | 2 |
Sektoral
| Health Technology | 26 |
| Consumer Services | 15 |
| Finance | 4 |
| Commercial Services | 4 |
| Energy Minerals | 2 |
Operativ
| Director/Board Member | 141 |
| Corporate Officer/Principal | 59 |
| Independent Dir/Board Member | 44 |
| Undergraduate Degree | 28 |
| President | 23 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Meghan Fitzgerald | 28 |
| Wan Li Zhu | 22 |
| John Climaco | 18 |
| Jim Momtazee | 17 |
| Donald Picker | 16 |
| Dan Gold | 16 |
| Andrew Lo | 16 |
| Keith Manchester | 15 |
| Faith Charles | 14 |
| Vivek Ramaswamy | 14 |
| Melissa Epperly | 13 |
| Eric Venker | 12 |
| Rakhi Kumar | 12 |
| Ilan Oren | 10 |
| Mayukh Sukhatme | 10 |
- Börse
- Insiders
- Amy Mahery
- Unternehmensverbindungen
